Transparency in Romania

The transparent interaction and the transfer of value between pharmaceutical companies and Healthcare Professionals and Healthcare Organizations represents an evidence of the correctness of the respective relationships, taking into consideration the best interest of all relevant stakeholders – the pharmaceutical industry, Healthcare Professionals and Organizations, patients and society in general.

 

Bayer Romania, an ARPIM member, is managing in a transparent manner all partnerships with Healthcare Professionals and Healthcare Organizations, providing the following reports:

 

Transfer of Value Disclosure Report as per National Legislation (ANMDM)

 

According to the Law no. 95/2006, governing the Healthcare Sector (art. 814) the pharmaceutical industry is disclosing all transfer of values made in relation with Healthcare Organizations or Professionals.

 

The report related to 2014 Transfer of Values can be accessed here and on the web page of National Drug Agency - Agentia Nationala a Medicamentului si Dispozitivelor Medicale.

 

The report related to 2015 Transfer of Values can be accessed here.

 

The report related to 2016 Transfer of Values can be accessed here.

 

Transfer of Value Disclosure as per ARPIM Code

 

In addition to Disclosure Report prepared as per the local legislation, as ARPIM member, Bayer discloses aggregately on an annual basis the Transfer of Value related to Research and Development activities.

 

The report related to 2015 R&D Transfer of Values as per APRIM Code can be accessed here.

 

The report related to 2016 R&D Transfer of Values as per APRIM Code can be accessed here.

 

The methodology related to 2016 Transfer of Value Disclosure can be accessed here.